BackRevelation Biosciences- Warrants(10/01/2027) Overview

Revelation Biosciences- Warrants(10/01/2027) Current Cash

Latest current cash for REVBW: $14M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$14.11M
↑ 280.97% YoYΔ $10.41M vs prior year quarter

Peer average

Loading

Revelation Biosciences- Warrants(10/01/2027) Current Cash History

Loading

Revelation Biosciences- Warrants(10/01/2027) vs. peers: Current Cash Comparison

Loading

Revelation Biosciences- Warrants(10/01/2027) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Revelation Biosciences- Warrants(10/01/2027) (REVBW) FAQ

As of the most recent data (March 2026), REVBW shows a current cash of $14M. That compares with $3.7M in the prior-year period — up 281.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REVBW's current cash is now $14M (was $3.7M) — a 281.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Revelation Biosciences- Warrants(10/01/2027) is outperforming or lagging.

Tracking REVBW's current cash over time shows whether Revelation Biosciences- Warrants(10/01/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $3.7M in the prior-year period — up 281.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Revelation Biosciences- Warrants(10/01/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $14M) with ownership activity and broader fundamentals.